Loading page
Loading page
Loading substance route
These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
There is considerable risk of physical harm when taking these combinations, they should be avoided where possible.
These combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.
May cause potentially dangerous vasoconstriction at high doses; the extreme potency of this compound increases the risk of accidental overdose leading to cardiovascular complications.
25iP-NBOMe emerged as a novel designer drug and was first documented in the scientific literature around 2014. Like other members of the NBOMe series, it represents an N-benzyl modification of an existing 2C-x compound—in this case, 2C-iP. The substance remains relatively obscure compared to more widely encountered NBOMe compounds such as 25I-NBOMe or 25C-NBOMe, with limited information available regarding its history of human use or cultural significance.
Controlled under the Misuse of Drugs Act 1971 through the N-benzylphenethylamine catch-all clause, which covers NBOMe compounds as a structural class. Class A substances carry the most severe penalties, with possession punishable by up to 7 years imprisonment and supply by up to life imprisonment.
12 sources cited